Vertex Pharmaceuticals is anchored by cystic fibrosis as launches lag, JOURNAVX and CASGEVY add little revenue, and growth is ...
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...
All-optical image processing has been viewed as a promising technique for its high computation speed and low power ...
Company on track to report ELEVATE-44-201 data from the first cohort in Q2 2026 and ELEVATE-45-201 data from the first cohort in mid-2026 –-- ...
Company on track to report ELEVATE-44-201 data from the first cohort in Q2 2026 and ELEVATE-45-201 data from the first cohort in mid-2026 - -- Expects to initiate global Phase 1/2 MAD clinical study ...
ASN Kidney Week, held in November, featured leading-edge science in kidney care, with evidence supporting new drugs to treat immunoglobulin A nephropathy, address chronic kidney disease in specific ...
Vertex, Inc. (NASDAQ: VERX) said it has been named one of Built In’s Best Places to Work in 2026, earning recognition as ...
Issued on behalf of QSE - Quantum Secure Encryption Corp. VANCOUVER – Baystreet.ca News Commentary — The digital perimeter has officially vanished. As autonomous systems take over the enterprise, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results